Private equity firm Advent International has completed its majority acquisition of Indian contract development and manufacturing organisati...

Shares of ASML Holding NV lost 2% and were among the top drags on the STOXX 600, despite forecasting sales growth of more than 25% for 2023.

Syngene is a fully integrated CRAMS company and Biocon has around 70% stake in it. Syngene also has a wholly-owned subsidiary in the US.

The pan-European STOXX 600 index rose 0.2 per cent by 0713 GMT - holding below all-time highs - with sectors considered more stable such as...

Speaking at a virtual event on vaccine manufacturing, Stephane Bancel said that additional technology transfers might dent their ability to...

These are some of the sectors and stocks in traders’ sights for their roles in the global vaccine rollout.

Bank shares tracked a decline in bond yields, shrugging off signs of a pickup in M&A activity after a report said Italy's Banco BPM and Fra...

The Cambridge, Massachusetts-based company said the vaccine candidate, mRNA-1273, appeared to produce an immune response in eight people wh...

Moderna’s experimental shot induces the body’s own cells to make virus-like proteins that stimulate an immune response and prepare for an a...

Britain's FTSE 100 jumped 0.9 per cent thanks to a weaker pound boosting London-listed multinational exporters.

Lonza Group AG agreed to buy Arch Chemicals Inc. for $1.2 billion in cash to create the world's biggest microbial - control business.